Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001207907 | SCV001379275 | uncertain significance | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2024-11-18 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 155 of the MPL protein (p.Glu155Val). This variant is present in population databases (rs780341646, gnomAD 0.05%). This missense change has been observed in individual(s) with severe anemia and thrombocytopenia (internal data). ClinVar contains an entry for this variant (Variation ID: 938642). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MPL protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001833827 | SCV002086023 | uncertain significance | Congenital amegakaryocytic thrombocytopenia | 2020-03-10 | no assertion criteria provided | clinical testing |